greenovation Biotech GmbH

Our core competence is the effective optimization and production of pharmaceutically highly-efficient glycoproteins in contained photo bioreactors. The production platform is based on bryotechnology (bryophytes = mosses), developed by greenovation. In this process mosses are genetically modified in a way that enables them to reproduce exactly the desired protein, for example an antibody for fighting cancer, according to a given blueprint. Our main focus is the production and optimization of cancer fighting antibodies as well as various other therapeutic proteins for different indications. We have already supplied our products to global customers for preclinical studies.


greenovation Biotech GmbH
Weipertstr. 8-10
74076 Heilbronn


Phone: +49 7131 766 936 0

email: info(@)


  • Research

Involved in research projects: